Notify me when Hound Partners, LLC files a new 13F portfolio report.
⭐ Subscribe ⭐| Quarter | Holdings | Value $ | Bought | Sold | Net | Top Holdings | Form Type | Filing Time |
|---|---|---|---|---|---|---|---|---|
| Q4 2025 | 36 | $721,290,523 | +$208,228,359 | -$233,306,426 | -$25,078,067 | CCL, PLTR, NVDA, NCLH, SE | 13F-HR | 17 Feb 2026, 17:08 |
| Q3 2025 | 30 | $778,597,703 | +$84,535,012 | -$123,638,319 | -$39,103,307 | CCL, GS, SE, NVDA, NCLH | 13F-HR | 14 Nov 2025, 15:58 |
| Q2 2025 | 28 | $739,894,070 | +$230,802,735 | -$86,564,398 | +$144,238,337 | CCL, SE, NVDA, NCLH, EXPE | 13F-HR | 14 Aug 2025, 16:23 |
| Q1 2025 | 17 | $504,265,932 | +$356,080,816 | -$44,690,181 | +$311,390,635 | NVDA, NCLH, CCL, EXPE, BIO | 13F-HR | 15 May 2025, 15:18 |
| Q4 2024 | 18 | $208,090,279 | +$58,549,668 | -$254,743,906 | -$196,194,238 | MSFT, DG, BIO, ENTG, ARW | 13F-HR | 14 Feb 2025, 16:12 |
| Q3 2024 | 17 | $399,517,346 | +$87,800,218 | -$259,874,121 | -$172,073,903 | IBIT, BKNG, FTNT, MSFT, GLNG | 13F-HR | 14 Nov 2024, 16:32 |
| Q2 2024 | 16 | $498,616,584 | +$312,013,200 | -$134,541,703 | +$177,471,497 | FTNT, IBIT, BKNG, BIO, GLNG | 13F-HR | 14 Aug 2024, 16:19 |
| Q1 2024 | 15 | $335,488,562 | +$85,131,499 | -$104,133,976 | -$19,002,477 | BIO, GLNG, HCA, IBIT, MSFT | 13F-HR | 15 May 2024, 16:18 |
| Q4 2023 | 12 | $320,936,079 | +$61,980,656 | -$205,783,468 | -$143,802,812 | BIO, HCA, VPU, GLNG, KEX | 13F-HR | 14 Feb 2024, 14:23 |
| Q3 2023 | 18 | $451,104,371 | +$115,887,626 | -$88,811,125 | +$27,076,501 | QQQ, BIO, VPU, MSFT, HCA | 13F-HR | 14 Nov 2023, 16:25 |
| Q2 2023 | 16 | $440,668,347 | +$118,979,556 | -$97,474,445 | +$21,505,111 | BIO, QQQ, MSFT, FIS, VOO | 13F-HR | 14 Aug 2023, 15:32 |
| Q1 2023 | 14 | $397,248,687 | +$132,338,426 | -$108,013,200 | +$24,325,226 | BIO, MSFT, QQQ, FIS, WDAY | 13F-HR | 15 May 2023, 15:35 |
| Q4 2022 | 13 | $338,192,419 | +$72,899,589 | -$302,810,328 | -$229,910,739 | HCA, QQQ, FRSH, MSFT, BIO | 13F-HR | 14 Feb 2023, 15:14 |
| Q3 2022 | 16 | $526,733,000 | +$17,974,008 | -$629,727,815 | -$611,753,807 | IWM, VOO, HCA, MSFT, ROST | 13F-HR | 14 Nov 2022, 15:40 |
| Q2 2022 | 24 | $1,232,697,000 | +$323,294,736 | -$320,376,062 | +$2,918,674 | VOO, IWM, MSFT, SPY, HCA | 13F-HR | 15 Aug 2022, 15:50 |
| Q1 2022 | 27 | $1,540,829,000 | +$374,296,971 | -$384,881,275 | -$10,584,304 | VOO, IWM, KEX, MSFT, VTWO | 13F-HR | 13 May 2022, 15:16 |
| Q4 2021 | 106 | $1,700,120,000 | +$256,208,266 | -$445,209,118 | -$189,000,852 | VOO, IWM, KEX, MSFT, HCA | 13F-HR | 14 Feb 2022, 13:49 |
| Q3 2021 | 206 | $1,825,410,000 | +$339,606,411 | -$406,273,593 | -$66,667,182 | VOO, MSFT, IWM, KEX, META | 13F-HR | 15 Nov 2021, 16:10 |
| Q2 2021 | 250 | $2,001,196,000 | +$207,075,732 | -$335,166,341 | -$128,090,609 | VOO, KEX, FTCHF, META, BABA | 13F-HR | 16 Aug 2021, 16:21 |
| Q1 2021 | 247 | $2,036,094,000 | +$880,684,745 | -$466,027,472 | +$414,657,273 | VOO, FIS, META, KEX, FTCHF | 13F-HR | 17 May 2021, 16:22 |
| Q4 2020 | 124 | $1,577,572,000 | +$473,271,107 | -$633,936,845 | -$160,665,738 | FTCHF, HCA, KEX, WDAY, META | 13F-HR | 16 Feb 2021, 16:28 |
| Q3 2020 | 94 | $1,457,977,000 | +$541,225,503 | -$247,063,628 | +$294,161,875 | FTCHF, KEX, META, WDAY, AER | 13F-HR | 16 Nov 2020, 17:04 |
| Q2 2020 | 49 | $1,086,082,000 | +$371,939,673 | -$611,350,430 | -$239,410,757 | AER, META, W, MSFT, SATS | Restatement | 14 Aug 2020, 19:54 |
| Q1 2020 | 36 | $1,061,499,000 | +$299,840,153 | -$225,329,751 | +$74,510,402 | CARG, SATS, META, MSFT, NXST | 13F-HR | 15 May 2020, 16:20 |
| Q4 2019 | 27 | $1,428,442,000 | +$221,427,772 | -$506,349,984 | -$284,922,212 | NXST, SATS, ARMK, META, CARG | 13F-HR | 14 Feb 2020, 16:13 |
| Q3 2019 | 25 | $1,564,895,000 | +$278,731,297 | -$649,432,567 | -$370,701,270 | CARG, NXST, META, SPR, MSFT | 13F-HR | 14 Nov 2019, 16:10 |
| Q2 2019 | 29 | $2,032,383,000 | +$292,250,850 | -$671,094,684 | -$378,843,834 | CARG, RPM, SPR, META, MSFT | 13F-HR | 14 Aug 2019, 16:17 |
| Q1 2019 | 30 | $2,326,665,000 | +$238,931,930 | -$1,531,109,239 | -$1,292,177,309 | SPR, CARG, META, RPM, MSFT | 13F-HR | 15 May 2019, 15:27 |
| Q4 2018 | 29 | $3,112,251,000 | +$389,991,022 | -$878,793,505 | -$488,802,483 | FOXA, SPR, META, HLT, RPM | 13F-HR | 14 Feb 2019, 14:08 |
| Q3 2018 | 32 | $4,301,462,000 | +$970,014,013 | -$847,820,697 | +$122,193,316 | FOXA, SPR, HLT, META, PCG | 13F-HR | 14 Nov 2018, 16:31 |
| Q2 2018 | 21 | $4,179,189,000 | +$692,355,221 | -$714,321,115 | -$21,965,894 | FOXA, SPR, META, HLT, CACC | 13F-HR | 14 Aug 2018, 15:10 |
| Q1 2018 | 22 | $3,971,407,000 | +$1,539,033,318 | -$1,055,758,094 | +$483,275,224 | FOXA, LKQ, MHK, CACC, SPR | 13F-HR | 15 May 2018, 16:21 |
| Q4 2017 | 21 | $3,637,394,000 | +$510,774,503 | -$1,275,774,308 | -$764,999,805 | HLT, LKQ, SPR, EXPE, NXST | 13F-HR | 14 Feb 2018, 18:00 |
| Q3 2017 | 24 | $4,156,264,000 | +$1,103,461,201 | -$1,177,127,100 | -$73,665,899 | HLT, SPR, EXPE, LKQ, ANDV | 13F-HR | 14 Nov 2017, 16:20 |
| Q2 2017 | 22 | $3,959,104,000 | +$787,379,778 | -$966,207,424 | -$178,827,646 | HLT, SPR, TSO, LKQ, EXPE | 13F-HR | 14 Aug 2017, 16:02 |
| Q1 2017 | 24 | $3,871,840,000 | +$1,230,120,472 | -$1,600,859,374 | -$370,738,902 | HLT, SPR, TSO, SERV, CACC | 13F-HR | 15 May 2017, 16:08 |
| Q4 2016 | 25 | $4,081,311,000 | +$852,983,152 | -$390,028,584 | +$462,954,568 | A104PS, SPR, TSO, SERV, CHTR | 13F-HR | 14 Feb 2017, 14:50 |
| Q3 2016 | 26 | $3,396,108,000 | +$587,110,422 | -$497,674,445 | +$89,435,977 | SPR, TSO, A104PS, SERV, BIDU | 13F-HR | 14 Nov 2016, 15:05 |
| Q2 2016 | 19 | $3,175,528,000 | +$819,784,599 | -$594,243,422 | +$225,541,177 | SPR, TSO, A104PS, BIDU, SERV | 13F-HR | 15 Aug 2016, 13:37 |
| Q1 2016 | 22 | $3,096,769,000 | +$566,708,102 | -$689,761,472 | -$123,053,370 | SPR, BIDU, FLT, TSO, CRI | 13F-HR | 16 May 2016, 15:34 |
| Q4 2015 | 20 | $3,712,784,000 | +$570,293,635 | -$653,782,163 | -$83,488,528 | SPR, VRX, FLT, CRI, TSO | 13F-HR | 16 Feb 2016, 14:42 |
| Q3 2015 | 21 | $3,962,141,000 | +$969,714,667 | -$591,710,970 | +$378,003,697 | VRX, SPR, TSO, FLT, CRI | 13F-HR | 16 Nov 2015, 12:49 |
| Q2 2015 | 20 | $4,025,174,000 | +$1,276,589,632 | -$1,324,658,510 | -$48,068,878 | VRX, SPR, CRI, TSO, FLT | 13F-HR | 14 Aug 2015, 15:22 |
| Q1 2015 | 24 | $3,965,894,000 | +$1,396,361,369 | -$683,586,537 | +$712,774,832 | VALEANT PHARMACEUTICALS INTL, SPR, CRI, CHTR, FLT | 13F-HR | 15 May 2015, 12:24 |
| Q4 2014 | 20 | $3,005,943,000 | +$553,673,235 | -$507,351,863 | +$46,321,372 | SPR, CRI, VRX, CHTR, FLT | 13F-HR | 17 Feb 2015, 11:23 |
| Q3 2014 | 19 | $2,741,360,000 | +$532,929,370 | -$154,556,433 | +$378,372,937 | VRX, CRI, SPR, CHTR, FLT | 13F-HR | 14 Nov 2014, 11:20 |
| Q2 2014 | 18 | $2,307,129,000 | +$353,041,758 | -$175,134,052 | +$177,907,706 | VRX, CRI, CHTR, SPR, FLT | 13F-HR | 12 Aug 2014, 15:49 |
| Q1 2014 | 18 | $2,029,557,000 | +$636,061,230 | -$248,694,367 | +$387,366,863 | VRX, CRI, CHTR, TSO, FLT | 13F-HR | 12 May 2014, 15:16 |
| Q4 2013 | 20 | $1,614,802,000 | $0 | $0 | $0 | VRX, CRI, FLT, GRA, CHTR | 13F-HR | 14 Feb 2014, 13:47 |